Role of newer fluoroquinolones in lower respiratory tract infections (vol 49, pg 709, 2002)

被引：8

作者：

Lode, H ^{[1
]}

Allewelt, M ^{[1
]}

机构：

[1] Chest Hosp Hecheshorn, Cent Clin Emil von Behring, Dept Chest & Infect Dis, D-14109 Berlin, Germany

来源：

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2002年 / 50卷 / 01期

关键词：

D O I：

10.1093/jac/dkf133

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：151 / 154

页数：4

共 14 条

[1] Comparative tolerability of the newer fluoroquinolone antibacterials [J].

Ball, P ;

Mandell, L ;

Niki, Y ;

Tillotson, G .

DRUG SAFETY, 1999, 21 (05) :407-421

[2]

Ball P., 2000, QUINOLONES, P2

[3]

BALL P, 2000, 3 EUR C CHEM MADR SP

[4] Clinical utility of the new fluoroquinolones for treating respiratory and urinary tract infections [J].

Blondeau, JM .

EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2001, 10 (02) :213-237

[5]

DEABATE CA, 1999, J RESP MED SA, V94, pE23

[6]

FILE T, 2000, 3 EUR C CHEM MADR SP

[7] Guidelines for management of adult community-acquired lower respiratory tract infections [J].

Huchon, G ;

Woodhead, M ;

Gialdroni-Grassi, G ;

Leophonte, P ;

Manresa, F ;

Schaberg, T ;

Torres, A ;

Didier, A ;

Dorca, J ;

El Ebiary, M ;

Roche, N .

EUROPEAN RESPIRATORY JOURNAL, 1998, 11 (04) :986-991

[8]

Lode H, 2002, J ANTIMICROB CHEMOTH, V49, P709, DOI 10.1093/jac/dkf024

[9]

NIEDERMAN M, 2000, J RESP MED SA, V94, pE23

[10] Guidelines for the management of adults with community-acquired pneumonia - Diagnosis, assessment of severity, antimicrobial therapy, and prevention [J].

Niederman, MS ;

Mandell, LA ;

Anzueto, A ;

Bass, JB ;

Broughton, WA ;

Campbell, GD ;

Dean, N ;

File, T ;

Fine, MJ ;

Gross, PA ;

Martinez, F ;

Marrie, TJ ;

Plouffe, JF ;

Ramirez, J ;

Sarosi, GA ;

Torres, A ;

Wilson, R ;

Yu, VL .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2001, 163 (07) :1730-1754

← 1 2 →